Unknown

Dataset Information

0

Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibition.

ABSTRACT:

SUBMITTER: Cuenca M 

PROVIDER: S-EPMC8968894 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibition.

Cuenca Marta M   Van Nieuwenhuijzen Niels N   Moesbergen Laura M LM   Bloem Andries A   Minnema Monique C MC   Peperzak Victor V  

Haematologica 20220401 4

Similar Datasets

Unknown Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma.
| S-EPMC7839214 | biostudies-literature
Unknown CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple Myeloma.
| S-EPMC6094395 | biostudies-literature
Unknown Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives.
| S-EPMC10290473 | biostudies-literature
Unknown Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma.
| S-EPMC11058938 | biostudies-literature
Unknown Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma.
| S-EPMC8327170 | biostudies-literature
Unknown γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.
| S-EPMC6871311 | biostudies-literature
Unknown B-Cell Maturation Antigen/CD19 Dual-Targeting Immunotherapy in Newly Diagnosed Multiple Myeloma.
| S-EPMC11273281 | biostudies-literature
Unknown Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma.
| S-EPMC11632591 | biostudies-literature
Unknown B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches.
| S-EPMC7214244 | biostudies-literature
Unknown Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
| S-EPMC6095983 | biostudies-literature